|
Apixaban 2.5 mg BID Clinical Trials
1 actively recruiting trial
Top Sponsors
- National Medical Research Center for Therapy and Preventive Medicine1
Indications
- Reduced-dose Apixaban1
- Anticoagulants / Administration & Dosage1
- Stroke Prevention in Patients With Atrial Fibrillation1
- Left Atrial Appendage Closure1
- Hemorrhage1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.